Mammographic Screening and “Overdiagnosis”
Authors:
- Daniel B. KopansDKDaniel B. Kopans
- Robert A. SmithRSRobert A. Smith
- Stephen W. DuffySDStephen W. Duffy
- 1 September 2011
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 260 (3) , 616-620
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialThe Lancet Oncology, 2011
- Absolute Numbers of Lives Saved and Overdiagnosis in Breast Cancer Screeninq, from a Randomized Trial and from the Breast Screening Programme in EnglandJournal of Medical Screening, 2010
- Declining Death Rates Reflect Progress against CancerPLOS ONE, 2010
- An estimate of overdiagnosis 15 years after the start of mammographic screening in FlorenceEuropean Journal of Cancer, 2009
- Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. womenBreast Cancer Research, 2007
- Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening ProgramThe Breast Journal, 2006
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerNew England Journal of Medicine, 2005
- Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort studyBMJ, 2004
- The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the diseaseEuropean Journal of Cancer, 2003
- Spontaneous Regression of CancerAnnals of Surgery, 1956